Immunovant (NASDAQ:IMVT – Free Report) had its price objective decreased by Bank of America from $38.00 to $33.00 in a ...

The company plans to use results from its Phase III myasthenia gravis study to support its pipeline candidate IMVT-1402 over the trial’s batoclimab. Wednesday, Immunovant, Inc. (NASDAQ ...

Immunovant stock opened at $19.64 on Thursday. Immunovant has a 1 year low of $17.01 and a 1 year high of $34.47. The firm has a 50 day moving average price of $20.86 and a 200 day moving average ...

Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire David Einhorn. In this article, we are going ...

OmniAb’s (OABI) stock tumbled roughly 25% this week after financial results for Q4 reflected a mix of revenue growth tempered by a downturn in ...

In this article, we will discuss the 10 Best Stocks to Buy According to Billionaire David Einhorn. David Einhorn is a highly ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Investing.com -- The euro is to reverse its losses sustained against the dollar during the fourth quarter of 2024 as the curtain draws to a close on 'American exceptionalism.' "We project that the ...

Explore SpringWorks Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SWTX. WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last ...